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Accuracy of Computerized Tomography in Determining Hepatic Tumor 
Size in Patients Receiving Liver Transplantation or Resection 
By Raj Mittal, Charles Kowal, Thomas Storzl, David Van Thiel, Klaus Bron, 
Shunzaburo Iwatsuki, Robert Schade, William Straub, and Andrew Dekker 
Computerized tomography (CT) of liver is used in on-
cologic practice for staging tumors, evaluating re-
sponse to treatment, and screening patients for he-
patic resection. Because of the impact of CT liver scan 
on major treatment decisions, it is important to assess 
its accuracy. Patients undergoing liver transplanta-
tion or resection provide a unique opportunity to test 
the accuracy of hepatic-imaging techniques by com-
parison of findings of preoperative CT scan with those 
at gross pathologic examination of resected speci-
mens. Forty-one patients who hod partial hepatic re-
section (34 patients) or liver transplantation (eight 
patients) for malignant (30 patients) or benign (11 
T HE ASSESSMENT of tumor response to treatment is an essential part of clinical on-
cology. as well as a critical factor in oncologic 
research. I-' This function may be easily per-
formed if the tumor has an associated serologic 
marker that correlates well with the extent of 
disease. such as in testicular cancer. gestational 
trophoblastic cancer. or myeloma. More fre-
quently. however. as in liver tumors. assessment 
of response to treatment is dependent on the 
physical measurement of the tumor mass or on 
the use of various radiologic techniques. 
Substantial variations have been reported in 
the physical measurement of tumor mas~es or 
liver size. I Moreover. the usefulness of hepato-
megaly in the assessment of tumor response is 
further compromised by recent work showing 
that intrahepatic metastases may enlarge without 
significantly changing the size of the liver . .j Var-
ious noninvasive radiologic methods have been 
used to assess intrahepatic lesions in an attempt 
to overcerne the limitatiol'ls of physical examina-
tion. These methods include radionuclide scin-
tigraphy. ultrasound (US). and computerized to-
mography (CT).5 Radionuclide (RN) scan is 
more sensitive in the detection of diffuse nonneo-
plastic liver disease such as cirrhosis. hepatitis. 
and cholangitis than CT scans. 6 CT. however. is 
superior to RN in the detection of biliary obstruc-
tion. 6 In a comparative study of US and CT in the 
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patients) tumors were evaluable. Eight (47%) of 17 
patients with primary malignant liver tumors, four 
(31%) of 13 patients with metastatic liver tumors, 
and two (20%) of 10 patients with benign liver tu-
mors hod tumor nodules in resected specimens that 
were not apparent on preoperative CT studies. These 
nodules varied in size from 0.1 to 1.6 cm. While 11 of 
14 of these nodules were < 1.0 cm, three of 14 were 
> 1.0 cm. These results suggest that conventional CT 
alone may be insufficient to accurately determine the 
presence or absence of liver metastases, extent of 
liver involvement, or response of hepatic metastases 
to treatment. 
evaluation of focal liver disease. US was found 
to be more sensitive but CT had higher specific-
ity and provided more information about intra-
hepatic masses and extrahepatic disease. if pres-
ent. '7 Overall. when compared to either US or RN 
scans. CT is presently considered to be the single 
best examination to determine both the presence 
and the extent of space-occupying lesions within 
the liver. 8-10 CT scanning. therefore, has become 
an accepted method for defining tumor response 
to treatment. 
Determination of the accuracy of imaging 
techniques in the abdomen such as CT. however. 
presents considerable difficulty. especially in the 
liver. Calibration of imaging techniques, like 
CT. for accuracy has depended on post-mortem 
examination. I I. Ie or on scanning artificial tumor 
masses. D In patients with neoplastic disease in 
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earlier stages, the detennining of CT accuracy 
has not been possible. 
Recent efforts at the University of Pittsburgh 
have focused on the use of liver transplantation. 
and the use of partial liver resection, such as 
trisegmentectomy, in the management of prima-
ry and secondary hepatic malignancies. '4-'6 Ev-
ery patient has an abdominal CT scan perionned 
shortly before the operative procedure. Each pa-
tient in this population, therefore, provides a 
unique opportunity for the study of hepatic CT-
scan accuracy, since their liver is removed, and 
is available for subsequent study. Thus, a com-
parison of the tumors noted in the preoperative 
CT liver scan with that of the tumors noted at the 
time of gross pathologic examination of the re-
sected specimen affords a measure of the accura-
cy of CT-liver scans. 
MATERIALS AND METHODS 
Forty-two patients receiving liver transplantation, or partial 
hepatic resection, for benign or malignant tumors were studied. 
All patients had cr studies of the liver, with and without con-
trast, prior to surgery, using Conray contrast material SM~ (150 
mLl given intravenously (IV). Approximately half of the con-
trast was administered as a rapid IV bolus and the other half was 
infused over five to 10 minutes. Due to a history of previous 
allergic reactions, one patient with hepatic hemangiomas did not 
receive contrast. 
Imaging studies were perfonned on a cr scanner <model no. 
8800, General Electric) with a scan time of 6.4 seconds. Serial 
transverse section images were obtained at IO-mm intervals, 
except in one patient where I 5-mm intervals were used. Patients 
with cr scans showing metallic-clip artifacts were considered 
inadequate for interpretation. One patient with a false-negative 
CT scan, secondary to metallic clip artifact. was excluded from 
the study. All patients underwent one or more additional imag-
ing procedures, such as US, RN scan. andlor angiography at 
either the University of Pittsburgh or at the referring hospital. 
The results of each patient's cr studies were compared with 
the gross findings of their resected liver specimens. Tumor nod-
ules that were apparent on the gross pathology specimen, but 
were completely missed on the CT scan were noted for size, 
frequency, and tumor type. In patients with cholangiocarcino-




Seventeen patients had primary hepatic malig-
nancies: 14 hepatomas and three cholangiocar-
cinomas. Thirteen patients had metastatic liver 
tumors; 10 with colorectal carcinoma, one with 
hypernephroma, and two with squamous-cell 
carcinoma of unknown primary. Eleven patients 
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had benign liver tumors; seven with hemangioma 
and four with hepatic adenoma. 
Surgical Procedures 
Patients received either a partial hepatic re-
section or liver transplantation. Partial hepatic 
resections were either trisegmentectomy or lo-
bectomy. Forty-two surgical procedures were 
perfonned on the 41 patients in the study. Thirty-
four patienh; underwent partial hepatic resec-
tions; 12 had lobectomy and 22 had triseg-
mentectomy. Eight patients received liver 
transplantation. One patient with multiple hepat-
ic adenomas received two surgical procedures: a 
right trisegmentectomy and a liver transplanta-
tion (one-year later) for recurrent disease in the 
remaining left lobe_ 
CT Scan Accuracy 
In this selected population. preoperative CT 
scan accurately detected the presence of nodules 
in the liver in all patients. CT scan detection of 
the extent or number of tumor nodules were less 
accurate than the detection of tumor presence or 
absence. In 27 (66%) of 41 patients, tumor nod-
ules were correctly detected by the CT scan. 
However, in 14 (34%) of 41 patients preoper-
ative CT did not detect all the tumor nodules and 
additional tumor nodules were discovered on the 
gross pathologic examination of the resected liv-
er specimens (Table 1). Malignant liver tumors 
appeared to have a higher incidence ofCT-unde-
Table 1. Patients with Additional Tumor Nodules 


































1 .. ' .. 1 (34) 
NOTE_ Data in parentheses are percentage. 
.. 
C1 LIVER SCAN ACCURACY 
tected tumor nodules (12 [40%] of 30) than did 
benign liver tumors (two [20%] of 10) but the 
difference was statistically not significant. Eight 
(47%) of 17 patients with primary malignant tu-
mors and four (31 %) of 13 patients with liver 
metastases had CT-undetected tumor nodules . 
Figures 1 and 2 show a tumor nodule that can be 
seen on the resected specimen, but which was not 
seen on the CT-liver scan. 
Table 2 shows the size of the CT-undetected 
tumor nodules with respect to tumor histology. 
These nodules were generally small, and varied 
in size from 0.1 to 1.6 cm. While 11 of 14 nod-
ules were < 1.0 cm, three of 14 were> 1.0 em in 
diameter. 
DISCUSSION 
Scintigraphy, sonography, and CT are the var-
ious radiologic modalities used in the noninva-
sive evaluation of hepatic neoplasms.' In the de-
tection of neoplasia, CT scan generally has been 
reported to have a low rate of false positives 
(4%-12%) and false negatives (4%).6.8 CT scan, 
in contrast to RN scan, is more specific in differ-
entiating between various focal hepatic lesions 
such as abscesslhematoma, cyst, hemangioma, 
and other tumors." Comparisons of the efficacy 
of these imaging modalities depends to a large 
extent on the current technical aspects of the mo-
dality. For example, earlier studies using CT 
scanners with scan times of 2.43 and 2.7 minutes 
respectively, claimed US to be the most accurate 
modality for the evaluation of hepatic space-oc-
cupying lesions. 18•19 More recent studies, with 
faster total body scan times of 18 seconds and 
less roentgenogram diffraction by using narrow-
er window widths, have shown CT to be equal, 
or superior, to US and RN scans in evaluating 
hepatic neoplasms. 7-10 
Cancer patients receiving hepatic resection or 
transplantation are an ideal population in which 
to study the accuracy of hepatic-imaging tech-
niques. The imaging procedure in this setting is 
usually done shortly before the operative proce-
dure. Following resection, a comparison of the 
resected gross pathology specimen with the pre-
operative imaging technique can be made. The 
use of a short interval between the imaging pro-
cedure and the surgical resection minimizes pos-
sible time delay artifacts in assessing the accura-
cy of the imaging technique. The comparison of 
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FI,. 1. Top, mltltlle, ami bottom: CT KGn of the 
IIv.r showln, a sln,l. tumor mall In the rI,ht lobe of 
the IIv.r. 
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Fig. 2. Resected liver specimen showing an addi-
tional tumor nodule near anterior surface of the liver 
that was not seen on the CT liver scan. 
the resected gros~ pathology specimen with the 
pre()peratiw imaging technique al~o allows for a 
more detailed correlation than is possible with 
other techniques. 
This <;fudy was undertaken to assess the accu-
racy of CT scans in patients with hepatic neo-
plasms. Our data show that a substantial propor-
tion of the patients (349C) had additional tumor 
nodules that were not detected by the preoper-
ative CT scan and that 229C of the missed lesions 
were> 1.0 cm in diameter. Since the results of a 
CT scan are frequently used for making manage-
ment decisions in oncologic patients. the results 
from our study have two implications. One in-
volves the use of CT scans to initiate a particular 
therapeutic procedure. and the other involves the 
u"e of CT to evaluate tumor response secondary 
to treatment. 
CT to Initiate Therapy 
CT scan of the liver is frequently used as a 
staging procedure for many tumors. ~lD The results 
of this staging procedure predicates. to a large 
extent. the direction of subsequent treatment. 
For example. the presence or absence of liver 
metastases is of major concern in patient~ with 
primary gastrointestinal tumors. A false-nega-
tive CT scan of the liver may lead to the use of 
unnecessary surgical procedures or may preclude 
the use of specialized procedures such as hepatic 
artery infusion chemotherapy. 
Additionally. CT liver scans may be used to 
stage patients as potential candidates for hepatic 
resection or transplant. The role of liver trans-
plantation in the management of patients with 
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unresectable primary hepatic tumors is still being 
investigated. 1DiK~f~" Partial hepatic resection for 
liver metastases in certain tumors may provide 
for a high actuarial probability of long disease-
free survival. 21.28 Data from this study would sug-
gest that 34o/c of the patients viewed as candi-
dates for surgical resection by means of 
conventional CT may have additional tumors 
that may contraindicate the use of surgical resec-
tion. In this setting. intraoperative palpation ot 
the liver. as a means of further detecting liver 
neoplasms may. like CT scans. also be subject to 
varying degrees of accuracy. Our data would 
indicate that about 26o/c of the patients will be 
expected to have CT-undetectable lesions that 
are < 1.0 em in diameter. It is unclear as to the 
reliability or the validity of intraoperative palpa-
tion in detecting lesions < 1.0 em in diameter 
within a hepatic parenchyma itself many centi-
meters in thickness. The use of CT alone. there-
fore. to select patients as candidates for surgical 
resection of hepatic neoplasms would seem to be 
insufficient and may need to be supplemented 
with other imaging procedures. 
Hepatic angiography has been traditionally 
used to detect the extent and resectabilitv of the 
hepatic tumors and to delineate the ;'ascular 
anatomy in patients undergoing hepatic re-
section. 241(l Infusion hepatic angiography can 
enhance the parenchymal phase of the angio-
gram24 " and has been reported to detect smaller 
hepatocellular carcinomas as compared to con-
ventional hepatic angiography.'2 Recently. CT 
arteriography ha~ been shown to detect addition-
al tumor nodules that were missed by other imag-
ing procedures and/or selective angiography in 
up to 559C of patients. rendering initial neo-
plasms unreseclable. ".1J Dynamic sequential CT 
Table 2. Correlation of Tumor Type and Undetected 
Nodule Size 
Nodule Size 
Tumor Type < 1 em > 1 em 
Hepatoma 6 1* 
Cholangiocarcinoma 1 0 
Colon-metastatic 2 2t 
Hemangioma 2 0 
Total 11 3 
NOTE. Data are no. of patients. 
*Multiple nodules varying in size from 0.1 em to 1.6 em. 
tTwo patients with single 1 .S-em nodules. 
CT LIVER SCAN ACCURACY 
with table incrementation during arterial portog-
rarhy (DSCTI-AP) ha~ been claimed as the most 
~ensilive means of detecting small intrahepatic 
lesions. as compared to conventional imaging 
procedures and angiography. l~_KD- The lesions de-
tected only by DSCTI-AP varied from 2 to 0.5 
em in diameter." Dynamic sequential CT with 
table incrementation during arterial portography 
is particularly useful in evaluating small tumors 
in the left lateral segment of the liver and inva-
sion of the liver hilum and the portal vein. Jb .'7 
The sensitivity of CT can also be increased by 
hepatic specific contrast agents. such as ethio-
dized oil emulsion 13. ;,--:2 Ethiodized oil emul-
~IIFn 13 increases the density of normal liver and 
spleen parenchyma without affecting the density 
of the tumor. This increased density difference 
leads to detection of increased number of lesions 
In pOSlcontrast scan~KD:: Ethiodized oil emulsion 
13 i~ also of \'alue in areas of the liver that usually 
are poorly visualized. that is. dome of the right 
lobe and the left lobe .':1 
CT t(l EWiluate Therapy 
In contrast to the use of CT in the staging of 
patients. where the results will be u~ed to initiate 
a therapeutic direction. CT may be used to evalu-
ate the results of a current therapy. Unfortunate-
Iv. little information exists as to the use of CT 
accuracy in determining the extent of response. 
either complete or partial. 2.2(1 in the liver to treat-
ment. Response to therapy as evaluated by CT 
641 
may be determined by inspection and/or meas-
urement of a particular tomographic section or by 
calculation of the entire tumor volume across all 
tomographic sections in which it appears. It has 
been reported that evaluation of individual tomo-
graphic sections without calculating the entire 
volume is frequently inaccurate and can miss a 
20o/c-80lk (range. 20-150 mll change in initial 
absolute volume. 2R In contrast. CT -tumor vol-
ume calculations are more accurate.U4.' but are 
also more time consuming and are not always 
readily available to the clinician. Determination 
of the accuracy of CT in evaluating tumor re-
sponses in the liver is important since the report-
ing of high response rates (up to 830t) is current-
ly being used as part of the rationale for the 
treatment of patients with HA I chemothera-
py.214445 Data from our study would further sug-
gest that CT alone is insufficient to establi~h that 
patients with previously identifiable disease have 
achieved a complete response. or complete dis-
appearance of measurable disease. in response to 
treatment. 
In conclusion. CT of the liver with and without 
IV contrast can miss tumor nodules up to 1.6 em 
in 340t of the patients studied. Until technical 
capabilities improve to detect lesions <2 em reli-
ably. conventional CT findings alone may be 
insufficient to accurately determine the presence 
or absence of liver metastases. extent of liver 
involvement. or response of hepatic metastases 
to treatment. 
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